Floxuridine

Catalog No.S1299 Synonyms: Deoxyfluorouridine, FDUR, NSC 27640

Floxuridine Chemical Structure

Molecular Weight(MW): 246.19

Floxuridine is an antineoplastic antimetabolite, used in the treatment of colon carcinoma and colorectal cancer that has metastasized to the liver.

Size Price Stock Quantity  
USD 97 In stock
USD 297 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective DNA/RNA Synthesis Inhibitors

Biological Activity

Description Floxuridine is an antineoplastic antimetabolite, used in the treatment of colon carcinoma and colorectal cancer that has metastasized to the liver.
In vitro

Floxuridine exhibits higher affinity for PEPT1 than the corresponding 5'-O-mono amino acid ester prodrugs. [1] Floxuridine combined with Leucovorin results in synergistic inhibitory effects on growth of human T-lymphoblast leukemia cells. [2] Floxuridine significantly inhibits the uptake of both [(3)H]-inosine and [(3)H]-adenosine (60-70% of control), while its amino acid ester prodrugs including Val, Phe, Pro, Asp, and Lys esters exhibits markedly decreased inhibition potency (10-30% of control). [3] Floxuridine inhibits cell proliferation by more than 50% relative to the untreated control cells at 36 days, the cell numbers still increases fourfold compared with the initial cell density. Floxuridine results in prolonged effects on the proliferation of human Tenon's capsule fibroblasts in vitro. [4] Floxuridine (FUDR) is an ideal drug for hepatic arterial infusion (HAI) due to its short half life, steep dose response curve, high total body clearance, and high hepatic extraction. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
CCRF-CEM cell NV\KcWVLT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M{P0d3Rme3SnZDDpckB3cXS{bzDmc5IhfGinIHnubIljcXSrb36gc4Yh[2WubDDndo94fGhib3[gbJVu[W5iVDDsfY1xcG:kbHHzeI9q\CCFQ2LGMWNGVSClZXzsJIxqdmViKFHUR2MhS0OOIEGxPUktKEmFNUC9NE42KM7:TR?= NHXRUZgyOTlyOUexOi=>
CCRF-CEM NVzVbXdRT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MVfJckB3cXS{bzDjc45k\W62cnH0bY9vKHKncYXpdoVlKG[xcjC1NEUhcW6qaXLpeIlwdiCxZjDndo94fGhib3[gbJVu[W5ibHX1b4VucWFiY3XscEBtcW6nIFPDVmYuS0WPIIfpeIghcFCDUDCoNE4zKHWwaYSvcWwqNCCJSUWwQVAvODByNjFOwG0> NVjUUoVMOTF3OUe0NFQ>
LNCaP cells Ml\YR5l1d3SxeHnjbZR6KGG|c3H5 NUK0fXVyS3m2b4TvfIlkKGOxbnPlcpRz[XSrb36gbY4heHKxc4TheIUhe3CnY3nmbYMh[W62aXflckApWFODKTDwdo9lfWOrbnegbJVu[W5iTF7DZXAh[2WubIOsJGlEPTB;MD6wOlkzKM7:TR?= MnewNVIyPjFzNUe=
TSU cells NG\rZ4pEgXSxdH;4bYNqfHliYYPzZZk> NVO3d496S3m2b4TvfIlkKGOxbnPlcpRz[XSrb36gbY4hdm:wIIDyc5N1[XSnIIPw[YNq\mmlIHHueIlo\W5iKGDTRUkheHKxZIXjbY5oKGi3bXHuJHRUXSClZXzsd{whUUN3ME2wMlA2QCEQvF2= NW\qSpltOTJzNkGxOVc>
KBALB cell NGO2[pJEgXSxdH;4bYNqfHliYYPzZZk> MY\JckB3cXS{bzDj[YxtKGO7dH;0c5hq[2m2eTDh[4FqdnO2IFvCRWxDKGOnbHygcIlv\SBqdILhcpNnd3KvZXSg[oljem:kbHHzeEB{[XKlb33hJINmdGxibHnu[UktKEOFNUC9Ok4xOEVvMEWg{txO MoS5NVI3OjByN{[=
KBALB-STK cell MmLiR5l1d3SxeHnjbZR6KGG|c3H5 MXTJckB3cXS{bzDj[YxtKGO7dH;0c5hq[2m2eTDh[4FqdnO2IFvCRWxDNVOWSzDj[YxtKGyrbnXzJIV5eHKnc4Pl[EBqdiCKU2[tNUBVUyxiSVO1NF05NjhyRT2wOUDPxE1? MWSxNlYzODB5Nh?=
L1210 mouse leukemia cells NYL3ZYFrT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M3jWSVI1KGh? NIqwZ3lIem:5dHigbY5pcWKrdHnvckBqdiCOMUKxNEBud3W|ZTDs[ZVs\W2rYTDj[YxteyCjZoTldkAzPCCqIITy[YF1dWWwdDygTWM2OD1yLkCwOFEh|ryP MlHINVE4OjhzOUO=
L1210 mouse leukemia cells NFSxUWZIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MV:0PEBp MonrS5Jwf3SqIHnubIljcXSrb36gbY4hVDF{MUCgcY92e2VibHX1b4VucWFiY3XscJMh[W[2ZYKgOFghcHJidILlZZRu\W62LDDJR|UxRTBwMECwOlQh|ryP NX\pTINTOTF5MkixPVM>
L5178Y cell MX\Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MUXDc41x[XKjdHn2[UBqdmirYnn0bY9vKG:oIFy1NVc5YSClZXzsJIdzd3e2aDDpckB3cXS{bzCoZ49v[2WwdILheIlwdiC{ZYH1bZJm\CCob4KgOVAmKGmwaHnibZRqd25rLDDJR|UxRTBwMECwO|Yh|ryP NXrCdVR[Pjd5OUCwOy=>
L5178Y cells NUj3V2tCTnWwY4Tpc44h[XO|YYm= NEPKNXZKdmirYnn0c5J6KGOxbnPlcpRz[XSrb36gc4Yh[2:vcH;1coQhf2G|IHPhcIN2dGG2ZXSgc44hVDVzN{jZJINmdGy|IHL5JHsyPEOfTHX1JIlv[2:{cH;yZZRqd25uIFnDOVA:OiEQvF2= M3u1R|gzPDZ{Mkm=
L1210 mouse leukemia cells MXvGeY5kfGmxbjDhd5NigQ>? MUeyJIg> NGjh[4FVcHmvaXT5cIF1\SC|eX70bIF{\SCrbnjpZol1cW:wIHnuJGwyOjFyIH3veZNmKGyndXvlcYliKGOnbHzzJIFnfGW{IEKgbJIhfHKnYYTt[Y51NCCLQ{WwQVAvODB5OTFOwG0> MUCxNVczQDF7Mx?=
LM cells M{PoSWZ2dmO2aX;uJIF{e2G7 NHTT[2QzKGh? MkHGWIh6dWmmeXzheIUhe3mwdHjhd4UhcW6qaXLpeIlwdiCrbjD0bJlucWSrbnWgb4lv[XOnIHTl[olkcWWwdDDMUUBk\WyuczDh[pRmeiB{IHjyJJRz\WG2bXXueEwhUUN3ME21MlQh|ryP NFfzSWoyOTd{OEG5Ny=>
HT1080 cells Ml:2SpVv[3Srb36gZZN{[Xl? NV[xWVZlS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhVOTB6MDDj[YxteyCkeTDNWHQh[XO|YYmsJGlEPTB;MD6xPEDPxE1? MoDaNVc5ODR{M{G=
L1210 cells MoX6S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NVi5PGltPzJiaB?= NGPqXG9EgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhdW:3c3WgUFEzOTBiY3XscJMhSVSFQzDDR2wzOTliYYPz[ZN{\WRiYYOg[5Jwf3SqIILl[JVkfGmxbjDh[pRmeiB5MjDodpMtKEmFNUC9NE4xOTJizszN M2P2W|E4QTl5M{G5
HL60 cells MmT0S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NYfsc|hGPzJiaB?= M3jBPGN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIUFYxKGOnbHzzJGFVS0NiQ1PMJFI1OCCjc4Pld5Nm\CCjczDndo94fGhicnXkeYN1cW:wIHHmeIVzKDd{IHjyd{whUUN3ME2wMlAyOiEQvF2= NUnpRW4zOTd7OUezNVk>
CCRF-CEM cells NInvc4tIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MWm3NkBp NYry[WlUS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGNEWkZvQ1XNJINmdGy|IFHUR2MhS0OOIEGxPUBie3Onc4Pl[EBieyCpcn;3eIghemWmdXP0bY9vKGGodHXyJFczKGi{czygTWM2OD1yLkCxO{DPxE1? MnXhNVc6QTd|MUm=
L1210 cells MULHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MVu3NkBp NGrufmFEgXSxc4TheIlkKGGldHn2bZR6KGmwIH3veZNmKExzMkGwJINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiY3XscEBoem:5dHigZYZ1\XJiN{KgbJJ{NCCLQ{WwQVAvODF{IN88US=> Mn20NVgxPzh5NUe=
HL60 cells MXTHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MVu3NkBp M1H5U2N6fG:|dHH0bYMh[WO2aY\peJkhcW5iaIXtZY4hUEx4MDDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGOnbHyg[5Jwf3SqIHHmeIVzKDd{IHjyd{whUUN3ME2wMlAyOiEQvF2= M4rXZVE5ODd6N{W3
CCRF-CEM cells Ml\JS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MmrNO|IhcA>? NHfKRVJEgXSxc4TheIlkKGGldHn2bZR6KGmwIHj1cYFvKEOFUl[tR2VOKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gZ4VtdCCpcn;3eIgh[W[2ZYKgO|IhcHK|LDDJR|UxRTBwMEG3JO69VQ>? NWPCcJF1OThyN{i3OVc>
CCRF-CEM cells NWD4bHpVTnWwY4Tpc44h[XO|YYm= Mnn0OFghcA>? M{HjWGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDR3JHNUOHTTDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkCwOlMyKM7:TR?= MWmxPVc1PDh3OB?=
K562 cells MnnySpVv[3Srb36gZZN{[Xl? NXG4OnFFPDhiaB?= M{e1[WFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDLOVYzKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvPzl2M{Og{txO NHnGV40yQTd2NEi1PC=>
MOLT4 cells M1;VSWZ2dmO2aX;uJIF{e2G7 NYC5RnVXPDhiaB?= MmTWRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3PUHQ1KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvODN7OEGg{txO NF[xenoyQTd2NEi1PC=>
RPMI8266 cells MV3GeY5kfGmxbjDhd5NigQ>? Mn\mOFghcA>? NFvBNoRCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gVnBOUTh{Nk[gZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD63PVQ{OyEQvF2= M2XweFE6PzR2OEW4
human SR cells M4H0cWZ2dmO2aX;uJIF{e2G7 NFP4V4Q1QCCq NFnWeoNCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV3Ih[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4xOTJ3OTFOwG0> MlO3NVk4PDR6NUi=
A549 cells MYnGeY5kfGmxbjDhd5NigQ>? MWe0PEBp NXy1b45zSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGE2PDliY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5yMUK1PUDPxE1? Ml\zNVk4PDR6NUi=
EKVX cells MnrySpVv[3Srb36gZZN{[Xl? NGTLbXg1QCCq M1KyZ2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDFT3ZZKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVExKM7:TR?= NWXJZYQ3OTl5NES4OVg>
HOP62 cells MX\GeY5kfGmxbjDhd5NigQ>? MkXZOFghcA>? NUD1ZoNuSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhQWDZ{IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMEK1NVIh|ryP NUTleFVVOTl5NES4OVg>
HOP92 cells NYPZXpVVTnWwY4Tpc44h[XO|YYm= NV;rbZg{PDhiaB?= M4rh[mFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIU3A6OiClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjd7NEOzJO69VQ>? NW\hUWg3OTl5NES4OVg>
NCI-H226 cells MXzGeY5kfGmxbjDhd5NigQ>? M4Dwc|Q5KGh? NFrTWW9CdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUmNKNUh{Mk[gZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYm= M1;kXlE6PzR2OEW4
NCI-H23 M{XNUGZ2dmO2aX;uJIF{e2G7 MYS0PEBp Mn;rRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF7DTU1JOjNiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OTBizszN MUOxPVc1PDh3OB?=
NCI-H322 NX[1U3F3TnWwY4Tpc44h[XO|YYm= NETSSGM1QCCq NXr3bXd7SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJG5EUS2KM{KyUUBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlUxOTF7IN88US=> MlvkNVk4PDR6NUi=
NCI-H460 M1HzO2Z2dmO2aX;uJIF{e2G7 NFSwelA1QCCq M2K5UWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOR2kuUDR4MDDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkWwNVE6KM7:TR?= Mne5NVk4PDR6NUi=
NCI-H522 MmLVSpVv[3Srb36gZZN{[Xl? M1nzS|Q5KGh? NF;p[5lCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUmNKNUh3MkKgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD6wNFIh|ryP MVyxPVc1PDh3OB?=
COLO205 cells MoHKSpVv[3Srb36gZZN{[Xl? NXv2PZRpPDhiaB?= MlzlRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPPUG8zODViY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:Oi53MUG4PUDPxE1? MlTxNVk4PDR6NUi=
HCC2998 cells NHrHUnJHfW6ldHnvckBie3OjeR?= M1TTWVQ5KGh? NIDCTm1CdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTGNEOjl7ODDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1zLkW4OFg6KM7:TR?= NFzV[Y8yQTd2NEi1PC=>
HCT116 cells NHO2NpdHfW6ldHnvckBie3OjeR?= NFXVc5Q1QCCq NHjqTHBCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTGNVOTF4IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMECxJO69VQ>? M3y1e|E6PzR2OEW4
HCT15 cells NXTadIFFTnWwY4Tpc44h[XO|YYm= MUO0PEBp NELPclJCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTGNVOTViY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5zMkW4PUDPxE1? NXLTNIV4OTl5NES4OVg>
HT-29 cells Mn\NSpVv[3Srb36gZZN{[Xl? M2W3ZlQ5KGh? MXPBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSGStNlkh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NU46QTV{NjFOwG0> MYmxPVc1PDh3OB?=
KM12 cells MonwSpVv[3Srb36gZZN{[Xl? NYfhXohCPDhiaB?= MmWxRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFvNNVIh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9Nk42OTF6OTFOwG0> M{G2cVE6PzR2OEW4
SW620 cells MYHGeY5kfGmxbjDhd5NigQ>? MoPVOFghcA>? MlLKRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPXOlIxKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVYvOzB7NUeg{txO M3zz[VE6PzR2OEW4
SF268 cells M2DVZmZ2dmO2aX;uJIF{e2G7 NY\uN2ZwPDhiaB?= M{jZSmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTSlI3QCClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yOCEQvF2= MXuxPVc1PDh3OB?=
SF295 cells M2rmO2Z2dmO2aX;uJIF{e2G7 MWS0PEBp M2n0TWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTSlI6PSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjBzMkW5JO69VQ>? Ml3JNVk4PDR6NUi=
SF539 cells MXPGeY5kfGmxbjDhd5NigQ>? NEjQeZU1QCCq NGD5VZJCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV2Y2OzliY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5yM{m4NUDPxE1? MmroNVk4PDR6NUi=
SNB19 cells MWrGeY5kfGmxbjDhd5NigQ>? MY[0PEBp NHXJNJJCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV25DOTliY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OS57OUWyOkDPxE1? M4jlOlE6PzR2OEW4
SNB75 cells NYKwXldlTnWwY4Tpc44h[XO|YYm= NV61U25KPDhiaB?= NEXWZYVCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV25DPzViY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5zOUm1N{DPxE1? MoLqNVk4PDR6NUi=
U251 cells M2jQcWZ2dmO2aX;uJIF{e2G7 MU[0PEBp NEX6Wm5CdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gWVI2OSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjF{NUi5JO69VQ>? NUjCcJd7OTl5NES4OVg>
LOXIMVI cells MVzGeY5kfGmxbjDhd5NigQ>? NELEZXM1QCCq NE\JV3pCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUG9ZUU2YSTDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkCyOVEzKM7:TR?= MXmxPVc1PDh3OB?=
MALME-3M cells M1jrZ2Z2dmO2aX;uJIF{e2G7 NGj6cVg1QCCq MXvBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVHMUWUuO01iY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:Py57NEOyPEDPxE1? NXHoSVA{OTl5NES4OVg>
M14 cells M{P3dWZ2dmO2aX;uJIF{e2G7 NVy1XHc5PDhiaB?= MlLDRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF2xOEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlE2QDR7IN88US=> NUn4dYVUOTl5NES4OVg>
SK-MEL-2 cells M33X[mZ2dmO2aX;uJIF{e2G7 MXu0PEBp NFLYN4hCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV2suVUWOLUKgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MUCg{txO NWrUXmdCOTl5NES4OVg>
SK-MEL-28 cells MVjGeY5kfGmxbjDhd5NigQ>? NFS2RZI1QCCq NVjSTlg{SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNMNU2HTD2yPEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2xMlk6PTJ4IN88US=> NXrrUIsxOTl5NES4OVg>
SK-MEL-5 cells MV;GeY5kfGmxbjDhd5NigQ>? MlnsOFghcA>? M{DpVWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT{1OTUxvNTDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkG5PVU{KM7:TR?= NGfNTGUyQTd2NEi1PC=>
UACC257 cells NYPwOpJ5TnWwY4Tpc44h[XO|YYm= NEm4fJI1QCCq Mn\uRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGXBR2MzPTdiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:Oy5zNkKyPEDPxE1? MUexPVc1PDh3OB?=
UACC62 cells NV\4[Xh2TnWwY4Tpc44h[XO|YYm= MoPqOFghcA>? MVjBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVVHDR|YzKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvODN7OEGg{txO NIXORYsyQTd2NEi1PC=>
IGROV1 cells MUPGeY5kfGmxbjDhd5NigQ>? M1;mO|Q5KGh? MmrrRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFnHVm9XOSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0zNjVzMUi5JO69VQ>? NXm5VFZjOTl5NES4OVg>
OVCAR-3 cells MmPUSpVv[3Srb36gZZN{[Xl? M4HyN|Q5KGh? M2HP[2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDPWmNCWi1|IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTJwNUGxPFkh|ryP MWixPVc1PDh3OB?=
OVCAR4 cells Mo\sSpVv[3Srb36gZZN{[Xl? M363NlQ5KGh? M{LwSGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDPWmNCWjRiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OTBizszN NVjOUnhtOTl5NES4OVg>
OVCAR5 cells NGXlcZhHfW6ldHnvckBie3OjeR?= MV20PEBp MUnBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iT2\DRXI2KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVYvOzB7NUeg{rxu NV[4VmFxOTl5NES4OVg>
OVCAR8 cells NYLjdXp3TnWwY4Tpc44h[XO|YYm= NUfiUYtFPDhiaB?= MmrNRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF;WR2FTQCClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjF{NUi5JO69VQ>? NYDvWYFbOTl5NES4OVg>
SKOV3 cells NVXrblRkTnWwY4Tpc44h[XO|YYm= NV3GO4dDPDhiaB?= MoXBRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLU3Y{KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVEvQTl3Mk[g{txO MVGxPVc1PDh3OB?=
786-0 cells NUjTeWZ5TnWwY4Tpc44h[XO|YYm= M{j3W|Q5KGh? NYiyU41{SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJFc5Pi1yIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMTFOwG0> M1uxRlE6PzR2OEW4
A498 cells M1\F[mZ2dmO2aX;uJIF{e2G7 NWnnepRFPDhiaB?= MVnBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUS5PEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2xMlI2QDl|IN88US=> MWGxPVc1PDh3OB?=
ACHN cells NV;3WINnTnWwY4Tpc44h[XO|YYm= MlnPOFghcA>? NGjrdllCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gRWNJViClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjB|MU[yJO69VQ>? NFzHfZoyQTd2NEi1PC=>
Caki1 cells MWfGeY5kfGmxbjDhd5NigQ>? M{PhSFQ5KGh? MkTwRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPhb4kyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvODNzNkKg{txO NF:4fowyQTd2NEi1PC=>
SN12C cells M3nJfGZ2dmO2aX;uJIF{e2G7 NXTwUGpuPDhiaB?= M4nHZmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTUlEzSyClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjF7OUWzJO69VQ>? NUjtNmhYOTl5NES4OVg>
TK10 cells NHS1fnlHfW6ldHnvckBie3OjeR?= NUPPfmtQPDhiaB?= MXTBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVFuxNEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME21MlAyOTh5IN88US=> NIjxXpUyQTd2NEi1PC=>
UO31 cells M2f1XmZ2dmO2aX;uJIF{e2G7 NGDoXIE1QCCq MmTZRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGXPN|Eh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4yOjV6OTFOwG0> MVOxPVc1PDh3OB?=
PC3 cells MY\GeY5kfGmxbjDhd5NigQ>? NYq4cVRrPDhiaB?= Mm\XRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDDN{Bk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlMyPjJ|IN88US=> NFHYeIQyQTd2NEi1PC=>
DU145 cells MWTGeY5kfGmxbjDhd5NigQ>? NWLXRoxRPDhiaB?= MU\BcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iRGWxOFUh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4zPTFzOTFOwG0> NYLPVmx4OTl5NES4OVg>
MCF7 cells M1G5RWZ2dmO2aX;uJIF{e2G7 M3THb|Q5KGh? MmrxRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4xODZ|MTFOwG0> MWixPVc1PDh3OB?=
NCI/ADR-RES cells MoSySpVv[3Srb36gZZN{[Xl? MWG0PEBp M1T1cmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOR2kwSUSULWLFV{Bk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2xMlI2QDl|IN88US=> M1fpOlE6PzR2OEW4
MDA-MB-231 cells NIrPV2RHfW6ldHnvckBie3OjeR?= M1TVR|Q5KGh? MX;BcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVTBMW1DNTJ|MTDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1|Lkm4NVA4KM7:TR?= MV2xPVc1PDh3OB?=
Hs 578T cells MVPGeY5kfGmxbjDhd5NigQ>? MkD1OFghcA>? NETSc2JCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTJMhPTd6VDDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1|Lkm4NVA4KM7:TR?= M3XxUFE6PzR2OEW4
MDA-MB-435 cells M{XZT2Z2dmO2aX;uJIF{e2G7 MmDROFghcA>? MnjvRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi12M{WgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;Mz6xOlIzQCEQvF2= NVixbGdnOTl5NES4OVg>
MDA-N cells MoC4SpVv[3Srb36gZZN{[Xl? NH3BWFk1QCCq MUDBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVTBMW4h[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NU4zPTh7MzFOwG0> MkW5NVk4PDR6NUi=
BT549 cells NH74S21HfW6ldHnvckBie3OjeR?= NIDYWFg1QCCq MWXBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQmS1OFkh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NUDPxE1? NGf2b2YyQTd2NEi1PC=>
T47D cells NU\hdYd7TnWwY4Tpc44h[XO|YYm= M1TvSVQ5KGh? NX:0RWFZSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHQ1P0RiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OS5{NUi5N{DPxE1? MkDsNVk4PDR6NUi=
HepG2 cells NVvIUY01S3m2b4TvfIlkcXS7IHHzd4F6 M{\CSVczKGh? MoDUR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTIVxTzJiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhTUN3ME2xPE45PCEQvF2= MWOxPVkyPzV{OB?=
A549 cells NYD1RpFZS3m2b4TvfIlkcXS7IHHzd4F6 MYK3NkBp MVTDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGVEPTB;OT63OEDPxE1? NIToOYIyQTlzN{WyPC=>
LAC cells NHTZfItEgXSxdH;4bYNqfHliYYPzZZk> NXzWPGNwPzJiaB?= MkL3R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUGFEKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGVEPTB;M{KuNFkh|ryP Mmq2NVk6OTd3Mki=
HeLa cells MY\DfZRwfG:6aXPpeJkh[XO|YYm= NHXoXZU4OiCq NEj5THZEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\UyjIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEWFNUC9NVAvOjZizszN MnLMNVk6OTd3Mki=
MDA-MB-231 cells MXjDfZRwfG:6aXPpeJkh[XO|YYm= NGfsXI9EgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJI93\XKneIDy[ZN{cW6pIIXyc4tqdmG|ZTDwcIF{dWmwb3flckBi[3SrdnH0c5ItKEmFNUC9NE4zOSEQvF2= MmPnNlA{PjNzM{C=
human ACHN cells MVHGeY5kfGmxbjDhd5NigQ>? NHnTUoFCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gRWNJViClZXzsd{BjgSCVUlKgZZN{[XluIFfJOVA:Oi5zIN88US=> NHn4T2YzODd|MkixNC=>
PC3 cells MmnySpVv[3Srb36gZZN{[Xl? NFftRXpCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gVGM{KGOnbHzzJIJ6KFOUQjDhd5NigSxiR1m1NF01Njl5IN88US=> NHjrUFYzODd|MkixNC=>
MDA-MB-231 cells Mnr0SpVv[3Srb36gZZN{[Xl? MXjBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVTBMW1DNTJ|MTDj[YxteyCkeTDTVmIh[XO|YYmsJGdKPTB;MD6xOkDPxE1? MlPsNlA4OzJ6MUC=
FM3A cells NEDBOIZHfW6ldHnvckBie3OjeR?= MkXRNkBl[Xm| NEnZbXFEgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhdW:3c3WgSm0{SSClZXzsd{Bi\nSncjCyJIRigXNiYomgZ492dHSncjDjc5VvfGmwZzDhcoFtgXOrczygTWM2OD1yLkCwPVQh|ryP NV[zdnRsOjF|M{CwNVQ>
HeLa cells M4P5d2Z2dmO2aX;uJIF{e2G7 M2\pSGN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDI[WxiKGOnbHzzJIlvKHC{ZYPlcoNmKG:oIEKwJJVOKHSqeX3p[Ilv\SxiSVO1NF05NjVizszN MoOzNlE{OzByMUS=
LLC cells NVi3RYo{S3m2b4TvfIlkcXS7IHHzd4F6 M1jrN|I1KGh? NVLaZ25IS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhVEyFIHPlcIx{KGGodHXyJFI1KGi{czDifUBz\XOjeoXybY4h[XO|YYmsJGlEPTB;MUSuNkDPxE1? M1vsblIyPTN4NES4
LLC cells NYrJdHdqS3m2b4TvfIlkcXS7IHHzd4F6 M1LCTVczKGh? MnXOR5l1d3SxeHnjbZR6KGGpYXnud5QhdW:3c3WgUGxEKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDy[ZNignW{aX6gZZN{[XluIFnDOVA:OiEQvF2= NVzUZ44{OjF3M{[0OFg>
RAW264.7 cells M{CyZWN6fG:2b4jpZ4l1gSCjc4PhfS=> MWG3NkBp MYHDfZRwfG:6aXPpeJkh[WejaX7zeEBud3W|ZTDSRXczPjRwNzDj[YxteyCjZoTldkA4OiCqcoOgZpkhemW|YYr1dolvKGG|c3H5MEBKSzVyPUOwJO69VQ>? NYjaXFJbOjF3M{[0OFg>
A549 cells M1vaUWN6fG:2b4jpZ4l1gSCjc4PhfS=> MonrO|IhcA>? MYPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIF{e2W|c3XkJIF{KGOnbHygeoli[mmuaYT5JIFnfGW{IEeyJIhzeyCkeTDXV3QuQCCjc4PhfUwhUUN3ME2wMlA1PyEQvF2= MlrRNlIzPDh6NU[=
A2780 cells MoTER5l1d3SxeHnjbZR6KGG|c3H5 MnjuOUBl[Xm| Ml\LR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVI4QDBiY3XscJMh[W[2ZYKgOUBl[Xm|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlAzPiEQvF2= NUHweYN3OjJ5M{i2N|Y>
LMTK cells MlfxR5l1d3SxeHnjbZR6KGG|c3H5 NGnZOoc2KGSjeYO= NFThWFZEgXSxdH;4bYNqfHliYXfhbY5{fCC2aIntbYRqdmVia3nuZZNmNWSnZnnjbYVvfCCvb4Xz[UBNVVSNIHPlcIx{KGGodHXyJFUh\GG7czDifUBOXFRiYYPzZZktKEmFNUC9OE42KM7:TR?= NFKy[oszOjd|OE[zOi=>
A549 cells NVL3W5NMS3m2b4TvfIlkcXS7IHHzd4F6 NGDNeHI4OiCq MUnDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDtbYNzd3CuYYTlJJJm[WSncjDt[ZRpd2RuIFnDOVA:OC5yMUK0JO69VQ>? MWqyNlg1PzBzOR?=
CEM cells M1PycmZ2dmO2aX;uJIF{e2G7 NEX5[Zc4OiCq MUjDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1XNJINmdGy|IHX4dJJme3OrbnegbJVu[W5iRV7UNUB1emGwc4DvdpRmeiCjZoTldkA4OiCqcoOgZpkh[2WubDDjc5VvfGmwZzDpckBxemW|ZX7j[UBw\iCQQl3QVkwhUUN3ME2wMlgh|ryP NEH3bWEzOTh7MkiyPS=>
Hela cells NFnrVIhHfW6ldHnvckBie3OjeR?= Mn\ZO|IhcA>? Mlz5R5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjlUIEh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IHPlcIwh[2:3boTpcoctKEmFNUC9NE4xPSEQvF2= M2XMXlIyQDl{OEK5
CEM/0 cells MVHGeY5kfGmxbjDhd5NigQ>? NWPOUlVPPzJiaB?= MWjDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1XNM|Ah[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IHPlcIwh[2:3boTpcoctKEmFNUC9NE4xOjJizszN M4fpWVIyQDl{OEK5
L1210/0 cells MlXnSpVv[3Srb36gZZN{[Xl? MnTmOFghcA>? M3XRVWN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDMNVIyOC9yIHPlcIx{KGGodHXyJFQ5KGi{czDifUBk\WyuIHPveY51cW6pLDDJR|UxRTBwMECwPUDPxE1? M2PDfVIyQDl{OEK5
MCF7 cells M2fPUGN6fG:2b4jpZ4l1gSCjc4PhfS=> M4THeVczKGh? M2LqdWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1ETjdiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JHNTSiCjc4PhfUwhUUN3ME2xNk4yQSEQvF2= MW[yN|g3PzZyMx?=
HeLa cells NFvZW25EgXSxdH;4bYNqfHliYYPzZZk> MkjPO|IhcA>? MoHhR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTIVN[SClZXzsd{Bi\nSncjC3NkBpenNiYomgV3JDKGG|c3H5MEBKSzVyPU[uOUDPxE1? NHr3W2YzOzh4N{[wNy=>
HL60 cells M2DjUHBzd2yrZnXyZZRqd25iYYPzZZk> NYDP[ZduPzJiaB?= Ml;XRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKTE[wJINmdGy|IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;uJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;MD6yOEDPxE1? NV;y[oFrOjV4NES2O|Q>
SW707 cells MorsVJJwdGmoZYLheIlwdiCjc4PhfS=> NX[2U3lWPzJiaB?= MYLBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFOZN{C3JINmdGy|IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;uJIFnfGW{IEeyJIhzeyCkeTDTVmIhdWW2aH;kMEBKSzVyPUKzMlg3KM7:TR?= MVGyOVY1PDZ5NB?=
LoVo cells NVq5R41xWHKxbHnm[ZJifGmxbjDhd5NigQ>? M4LsfVczKGh? MUXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEyxVn:gZ4VtdHNiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiN{KgbJJ{KGK7IGPSRkBu\XSqb3SsJGlEPTB;MUmuNFch|ryP MXiyOVY1PDZ5NB?=
BALB/3T3 cell M{PLdHBzd2yrZnXyZZRqd25iYYPzZZk> NIq2b|Q4OiCq NHz6RXFCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JI1wfXOnIFLBUGIwO1R|IHPlcIx{KGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDd{IHjyd{BjgSCVUlKgcYV1cG:mLDDJR|UxRTJ|Lkmg{txO NGDhWGszPTZ2NE[3OC=>
HFF cells NULUR5MzTnWwY4Tpc44h[XO|YYm= MXS3NkBp NFT2O|RCdnSrcHHyZZNqfGmlIHHjeIl3cXS7IHHnZYlve3RiVH;4c5Bt[XOvYTDnc45lcWliQWTDR{A2ODh|OTDpcoZm[3SnZDDpckBJTkZiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JIJmfGFvZ3HsZYN1d3OrZHHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvQTFizszN NGTlfGsyPzZ7OE[xPC=>
CCRFCEM cells NWTzRZRqTnWwY4Tpc44h[XO|YYm= M1rwU2N6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDR3JHS0WPIHPlcIx{KGK7IF3UWEBie3OjeTygTWM2OD1yLkK5JO69VQ>? NX3kNmFxOTd6MESyN|E>
RXF393 cells MkDvSpVv[3Srb36gZZN{[Xl? NYHsWHJvPDhiaB?= MV;BcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUmjGN|k{KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVMvQThzMEeg{txO NVXPV414OTl5NES4OVg>
HL-60(TB) cells MnrnSpVv[3Srb36gZZN{[Xl? M3TXclQ5KGh? MlTLRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjMMVYxMFSEKTDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkG5PVU{KM7:TR?= NIrjNXgyQTd2NEi1PC=>
L1210 cells NV;xcnpSTnWwY4Tpc44h[XO|YYm= MoD5NVUhdWmwcx?= MmDtTY5pcWKrdHnvckBw\iC2aIntbYR6dGG2ZTDzfY51cGG|ZTDpckBud3W|ZTDMNVIyOCClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJJRzcXSrdX2gdoVt\WG|ZTDmdo9uKFt3LUPIYYRmd3i7dYLp[Ilv\SCjZoTldkBxemWrbnP1ZoF1cW:wIH\vdkAyPSCvaX7zJIJ6KGyrcYXp[EB{[2mwdHnscIF1cW:wIHPveY51cW6pLDDJR|UxRTBwMECwOkDPxE1? MXWyNVM{ODBzNB?=
Colo-357 cells M1PRb2Z2dmO2aX;uJIF{e2G7 M3XxNFExOCEQvF2= MnHSNVUhdWmwcx?= M{TFNmFkfGm4aYT5JIF1KE2UUEWgbY4hcHWvYX6gR49tdy1|NUegZ4VtdHNiYYPz[ZN{\WRiYYOgOU1H\FWPUDDhZ4N2dXWuYYTpc44h[XRiMUCwJJVOKGGodHXyJFE2KG2rboO= NEH2XpMzODl|MEGyNy=>
KB cells M3jR[2N6fG:2b4jpZ4l1gSCjc4PhfS=> M3\WbVczKGh? M{fBPWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGtDKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDTVmIh[XO|YYmsJGlEPTB;OD62PUDPxE1? MWiyN|g3PzZyMx?=

... Click to View More Cell Line Experimental Data

Protocol

Solubility (25°C)

In vitro DMSO 49 mg/mL (199.03 mM)
Water 49 mg/mL (199.03 mM)
Ethanol 10 mg/mL (40.61 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 246.19
Formula

C9H11FN2O5

CAS No. 50-91-9
Storage powder
Synonyms Deoxyfluorouridine, FDUR, NSC 27640

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02529774 Not yet recruiting Resected Liver Metastases From Colorectal Cancer Ye Xu|Fudan University September 2015 Phase 2|Phase 3
NCT01938729 Active, not recruiting Intrahepatic Cholangiocarcinoma|Peripheral Cholangiocarcinoma|Cholangiolar Carcinoma|Cholangiocellular Carcinoma) (ICC) Memorial Sloan Kettering Cancer Center|Ohio State University|University of Texas Southwestern Medical Center|Washington University School of Medicine September 2013 Phase 1
NCT01862315 Recruiting Intrahepatic Cholangiocarcinoma|Peripheral Cholangiocarcinoma|Cholangiolar Carcinoma|Cholangiocellular Carcinoma Memorial Sloan Kettering Cancer Center|Ohio State University|University of Texas|Washington University School of Medicine May 2013 Phase 2
NCT01749397 Recruiting Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer National Cancer Institute (NCI) December 2012 Phase 1
NCT01692704 Completed Cholangiocellular Carcinoma University of Zurich April 2012 Phase 1|Phase 2
NCT01525069 Recruiting Cholangiocarcinoma|Liver Neoplasms Washington University School of Medicine April 2012 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Related Antibodies

DNA/RNA Synthesis Signaling Pathway Map

Related DNA/RNA Synthesis Products

Tags: buy Floxuridine | Floxuridine supplier | purchase Floxuridine | Floxuridine cost | Floxuridine manufacturer | order Floxuridine | Floxuridine distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID